Depreciation in USD of CAPRICOR THERAPEUTICS, INC. from 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Capricor Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2011 to Q3 2025.
  • Capricor Therapeutics, Inc. Depreciation for the quarter ending September 30, 2025 was $495K, a 37% increase year-over-year.
  • Capricor Therapeutics, Inc. Depreciation for the twelve months ending September 30, 2025 was $1.76M, a 29.8% increase year-over-year.
  • Capricor Therapeutics, Inc. annual Depreciation for 2024 was $1.43M, a 33.3% increase from 2023.
  • Capricor Therapeutics, Inc. annual Depreciation for 2023 was $1.07M, a 100% increase from 2022.
  • Capricor Therapeutics, Inc. annual Depreciation for 2022 was $533K, a 119% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)

CAPRICOR THERAPEUTICS, INC. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $1.76M $495K +$134K +37% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-10
Q2 2025 $1.63M $486K +$129K +36.2% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-11
Q1 2025 $1.5M $405K +$74K +22.3% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-14
Q4 2024 $1.43M $376K +$68.1K +22.1% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-26
Q3 2024 $1.36M $361K +$84.7K +30.6% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-10
Q2 2024 $1.27M $357K +$102K +40.1% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-11
Q1 2024 $1.17M $331K +$101K +44% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-14
Q4 2023 $1.07M $308K +$116K +60.5% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-26
Q3 2023 $953K $276K +$139K +102% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $813K $255K +$143K +127% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $671K $230K +$138K +149% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $533K $192K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-11
Q3 2022 $137K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $112K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $92.5K +$43.4K +88.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q1 2021 $49.1K +$17.2K +53.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q1 2020 $31.9K -$583 -1.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q1 2019 $32.5K +$9.24K +39.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q1 2018 $23.2K -$3.34K -12.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q1 2017 $26.6K +$7.17K +36.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q1 2016 $19.4K +$6.8K +53.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q1 2015 $12.6K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13

CAPRICOR THERAPEUTICS, INC. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.43M +$356K +33.3% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-26
2023 $1.07M +$536K +100% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-26
2022 $533K +$290K +119% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-11
2021 $244K +$104K +74.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-17
2020 $140K +$10.9K +8.46% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
2019 $129K +$14.3K +12.5% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-15
2018 $114K +$19.4K +20.4% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-27
2017 $95K +$9.08K +10.6% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-29
2016 $85.9K +$23.8K +38.3% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-22
2015 $62.1K +$30K +93.1% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-16
2014 $32.2K Jan 1, 2014 Dec 31, 2014 10-K 2016-03-30
2012 $6.26K -$1.25K -16.7% Jan 1, 2012 Dec 31, 2012 10-K 2013-06-21
2011 $7.51K Jan 1, 2011 Dec 31, 2011 10-K 2013-06-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.